Safety data Safety data Main navigation COVID-19 vaccines Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine Shingrix® AusVaxSafety is an active vaccine safety surveillance system that monitors the safety of vaccines in Australia. Using de-identified data reported directly from people receiving the vaccines (or their parent or carer), AusVaxSafety monitors adverse events following immunisation and facilitates early detection of potential vaccine safety issues. More information on AusVaxSafety active vaccine safety surveillance here. COVID-19 vaccines AusVaxSafety is conducting active surveillance of COVID-19 vaccine safety. Click here to access the latest data. Influenza vaccines AusVaxSafety is undertaking active surveillance of 2023 influenza vaccine safety. Click here to access the latest data. National Immunisation Program Schedule vaccines AusVaxSafety is undertaking active surveillance of NIP vaccine safety. Click here to access the latest data. Mpox (monkeypox) vaccine AusVaxSafety is conducting active surveillance of mpox vaccine safety. Click here to access the latest data. Shingrix® AusVaxSafety is undertaking enhanced surveillance of Shingrix® following addition to the NIP schedule. Safety data Main navigation COVID-19 vaccines Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine Shingrix® News & events All news & events 28 November 2023 | News AusVaxSafety monitoring monovalent Omicron XBB.1.5 variant COVID-19 vaccine safety 07 November 2023 | News AusVaxSafety commences enhanced surveillance of Shingrix® following addition to the NIP schedule 19 October 2023 | News AusVaxSafety surveillance of 2023 seasonal flu vaccines concludes with no safety issues identified 14 September 2023 | News Vaxtracker wins Hunter New England Health Excellence Award